• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Odyssey Medical unveils punctal plug, occluder results

Article

Odyssey Medical has introduced a punctal plug (Micro Flow) that is designed to provide a reversible means of partial occlusion by limiting the drainage of tears into the lacrimal duct.

Memphis, TN

-Odyssey Medical has introduced a punctal plug (Micro Flow) that is designed to provide a reversible means of partial occlusion by limiting the drainage of tears into the lacrimal duct. The device is intended for use in patients who have epiphora caused by a punctal stenosis or in instances where total punctal occlusion is considered too aggressive an approach.

In three sizes (small, medium, and large), the plug is available in sterile pre-loaded packaging that includes one pair of occluders and in non-sterile bulk packaging that includes five pairs.

In other news, the company announced results of a study showing a 92% retention rate for another occluder (Parasol). When Craig McCabe, MD, PhD, examined 108 patients who received the plug after artificial tears had failed to address their dry eye, 91% of them reported that their eyes had more moisture, and 77% reported fewer dry eye symptoms. Snellen acuity improved by one or more lines in 43% of the eyes, according to the company.

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.